Luyuan Li

Title: Innovations of Luyuan Li: A Pioneer in Fibroblast Growth Factor Analogues

Introduction

Luyuan Li, based in New City, NY, has made significant contributions to the field of biotechnology through his innovative work on fibroblast growth factor structural analogues. With a keen focus on enhancing the biological properties and receptor binding specificity of these factors, Li's research offers promising avenues for therapeutic applications.

Latest Patents

Luyuan Li holds a patent for "Surface loop structural analogues of fibroblast growth factors." His innovation involves modifications to the amino acid sequences in the ninth or tenth beta-strand of the growth factor, leading to stable folding of the molecule. These analogues are designed to maintain the overall secondary and tertiary structure of the original factor while being capable of binding with high affinity to heparin and members of the fibroblast growth factor receptor family. Specific embodiments of his invention include replacing the surface loop that connects the ninth and tenth beta-strands with sequences from other fibroblast growth factors or interleukins, resulting in analogues with distinct biological properties and receptor interactions compared to their native counterparts.

Career Highlights

Luyuan Li has worked with notable companies, including Yeda Research and Development Company and American Cyanamid Company. His involvement in these organizations has allowed him to collaborate with leading researchers and contribute to groundbreaking advancements in biotechnological research.

Collaborations

Throughout his career, Li has worked alongside esteemed colleagues such as Andrew P. Seddon and Peter Bohlen. These collaborations have further enriched his research and have been instrumental in driving forward the knowledge and application of fibroblast growth factor analogues within the scientific community.

Conclusion

Luyuan Li's groundbreaking work in the development of fibroblast growth factor analogues underscores his role as an innovator in biotechnology. His ability to alter amino acid sequences to achieve specific biological functions demonstrates the potential for novel therapeutic strategies that can arise from such research. As he continues to push the boundaries of innovation, Luyuan Li remains a key figure to watch in the field of biochemistry and molecular biology.